Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-24

Clinical Trial Update: Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug interaction between linerixibat and obeticholic acid in healthy subjects completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linerixibat (linerixibat)
  • Obeticholic acid (obeticholic acid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cholestasis | Phase 1 | Status: COMPLETED | Results posted: 2020-07-24